Osteoporosis, Hyperparathyroidism, & Myeloma

Assesses bone health and screens for conditions like osteoporosis, hyperparathyroidism, and multiple myeloma. Uses markers related to calcium balance, bone turnover, and immune activity to identify underlying bone or metabolic issues.

Ideal for: Aging adults, especially women, family history of osteoporosis, vitamin D or calcium deficiency, abnormal DEXA scan results, or abnormal immune activity

May help explain: Bone pain, frequent fractures, or musculoskeletal discomfort

Next steps after results: Increasing vitamin D and calcium intake, supporting bone health with nutrition and resistance training, potential followup with a clincian

Suggested frequency: Every 3–6 months during treatment; annually for those with risk factors

Biomarkers included (10): Total Protein, Albumin, Alpha-1 Globulin, Alpha-2 Globulin, Beta-1 Globulin, Beta-2 Globulin, Gamma Globulin, Intact Parathyroid Hormone, Serum Calcium, and Ionized Calcium

Osteoporosis affects 12.6% of adults aged 50 and older: 19.6% of women and 4.4% of men.